Sarah, a 53-year-old breast cancer survivor, has shared her struggle with a vanished libido and painful intimacy following her diagnosis in August 2021. After undergoing treatment including aromatase inhibitors, she describes the emotional and physical toll of a medically induced menopause.
The 2028 deadline for aromatase inhibitors
Following a diagnosis of a stage one, "grade two" tumour in August 2021, Sarah underwent a lumpectomy and radiotherapy . As reported in the source, she is now prescribed a five-year course of aromatase inhibitors that will continue until 2028. These medications are designed to suppress oestrogen production to lower the risk of cancer recurrence , but they effectively trigger a sudden, medically induced menopause.
Unlike the gradual transition of natural menopause, Sarah describes this shift as a "plunge." The physical manifestations were immediate and severe, including joint pain and hot flushes that occurred approximately 20 times per day. to manage the joint pain, Sarah maintains a regimen of three weights workouts per week to strengthen her muscles, as her doctor advised against Hormone Replacement Therapy (HRT) due to her history of hormone-induced cancer.
From daily intimacy in 2010 to once every three months
The emotional weight of Sarah's recovery is compounded by a drastic shift in her relationship with her husband, Andy. According to the report , the couple enjoyed nearly daily intimacy when they first met in 2010 while working on the show Angela And Friends. Over time, this frequency shifted to once a week after the birth of their children, Hunter and Autumn, but has now plummeted to roughly once every three months.
This decline is part of a broader, often overlooked trend in oncology where the focus on clinical survival overshadows the preservation of sexual health. For Sarah, the loss of libido is not merely a physical symptom but a source of profound guilt, as she feels unable to meet the physical needs of her partner. This highlights a critical gap in patient care: while the cancer is treated, the resulting "sexless months" can create a secondary psychological crisis for survivors and their partners.
How vaginismus and vaginal atrophy created a "wall"
Beyond the loss of desire, Sarah faced severe physical barriers to intimacy. She describes suffering from vaginal atrophy (vaginal dryness) and vaginismus, a condition involving the involuntary tightening of pelvic floor muscles. Sarah explains that this tightening creates a sensation similar to a "wall," making sexual intercourse agonising rather than pleasurable.
The interplay between physical pain and psychological anticipation created a "vicious circle." As Sarah began tensing up in anticipation of the pain, Andy eventually stopped initiating sex to avoid hurting her. This cycle demonstrates how the physiological side effects of aromatase inhibitors can fundamentally rewire the emotional dynamiics of a long-term partnership.
Why "try relaxing" failed Sarah's clinical needs
A significant point of frustration in Sarah's account is the inadequacy of the medical guidance she received. After being referred to a gynaecologist, Sarah was told to "try relaxing" and to use lubricant—advice she found entirely ineffective for the severity of her vaginismus. This raises urgent questions about the standard of care for cancer survivors: why are these specific, debilitating symptoms not more widely discussed in clinical settings?
Furthermore, Sarah notes that her own research online revealed a startling lack of discourse regarding these specific side effects among other breast cancer survivors. It remains unclear whether this silence is due to the social stigma surrounding female sexual dysfunction or a lack of patient-focused literature on the long-term effects of aromatase inhibitors. The source only presents Sarah's perspective, leaving the medical community's response to these failures unaddressed.
Comments 0